Macular degeneration is a progressive eye disorder that primarily affects the macula—the small central portion of the retina responsible for sharp, detailed vision. While it most commonly develops in people over 50, early recognition of risk factors and symptoms, timely diagnosis, and an appropriate care plan can help slow progression and preserve quality of life.

Who is at increased risk?

Several well-established factors raise the likelihood of developing age-related macular degeneration (AMD). Advancing age is the strongest risk factor, with incidence rising substantially after age 50. A family history of AMD points to genetic susceptibility. Lifestyle and health conditions also play a major role: cigarette smoking can roughly double the risk, and obesity, uncontrolled high blood pressure, elevated cholesterol, and cardiovascular disease are linked with more advanced disease. Ethnicity matters as well—Caucasian individuals tend to have higher rates of AMD. Extended exposure to ultraviolet (UV) light without eye protection is also considered a contributing factor. Understanding these elements helps people and clinicians prioritize screening and prevention.

What symptoms should you watch for?

Macular degeneration often starts gradually, so early symptoms can be subtle. Common warning signs include:

• Blurred or fuzzy central vision
• Difficulty recognizing faces or reading fine print
• Straight lines appearing wavy or bent (metamorphopsia)
• A dark, gray, or empty area in the center of vision
• Colors seeming duller or less vivid
• Trouble adjusting to low light
• Increased glare sensitivity

Because peripheral (side) vision is usually maintained, people may not notice a problem until central vision has declined. Regular eye checks are essential to detect AMD before vision loss becomes pronounced.

How is AMD diagnosed and followed?

A comprehensive eye exam by an optometrist or ophthalmologist is the first step. Typical components include a visual acuity test to assess clarity of sight and a dilated retinal exam to inspect the macula directly. Simple home screening with an Amsler grid can help patients monitor central vision between visits.

Advanced imaging tools provide detailed information about disease activity and progression. Optical coherence tomography (OCT) creates cross-sectional images of the retina, revealing fluid, swelling, or thinning of retinal layers. Fluorescein angiography uses a dye to illuminate blood vessel leakage or abnormal vessel growth in the macula. These tests guide both diagnosis and treatment choices and are commonly repeated during follow-up to measure response.

Treatment strategies and supportive options

There is no cure for AMD, but a range of treatments can slow progression and manage symptoms, especially when started early.

• Anti-VEGF injections: For wet (neovascular) AMD, regular injections into the eye inhibit vascular endothelial growth factor (VEGF), reducing abnormal blood vessel growth and leakage. These injections have dramatically improved outcomes for many patients.

• Photodynamic therapy (PDT): This approach combines a light-activated drug with laser light to target abnormal vessels, used in select cases.

• Laser therapy: In certain situations, lasers can seal leaking vessels, though this is less common than anti-VEGF therapy.

• Nutritional supplements: Specific vitamin and mineral combinations proven in clinical trials (AREDS and AREDS2 formulations) can reduce the risk of progression from intermediate to advanced AMD in some patients.

• Low vision aids: Magnifiers, high-contrast reading materials, text-to-speech devices, and other assistive technologies can help people maximize remaining vision and maintain independence.

• Lifestyle modifications: Quitting smoking, maintaining a healthy weight, exercising, protecting eyes from UV radiation with sunglasses and hats, and controlling blood pressure and cholesterol are all important.

Treatment plans are individualized based on whether the AMD is the dry (atrophic) form or the wet (neovascular) form, disease stage, and the patient’s overall health and preferences.

---

Treatment	Purpose	Typical use-case
Anti-VEGF injections	Stops abnormal vessel growth and reduces leakage	Wet AMD, often ongoing injections
Photodynamic therapy	Targets abnormal vessels with light-activated drug	Select wet AMD cases
Laser therapy	Seals leaking blood vessels	Limited situations in wet AMD
AREDS/AREDS2 supplements	May slow progression in intermediate AMD	Dry AMD at risk of progression
Low vision aids	Improves functional vision for daily tasks	Any stage with visual impairment

Cost estimates are approximate and will vary by region, provider, and insurance coverage. Please consult your healthcare provider or insurer for specific pricing information.

---

How to protect your eyes and reduce risk

Although not every case can be prevented, adopting healthy habits helps lower risk and supports eye health. Eat a diet rich in leafy green vegetables, colorful fruits, and omega-3-rich fish. Regular physical activity supports cardiovascular and ocular circulation. Avoid smoking and limit prolonged, unprotected sun exposure. Keep blood pressure and cholesterol under control and attend scheduled eye exams—especially if you are over 50 or have a family history of AMD. Your eye care professional may recommend supplements when appropriate.

Early detection and ongoing monitoring give the best chance to slow vision loss. If you notice any changes in central vision—such as distortion, blurriness, or a blind spot—seek prompt evaluation.

This article is for informational purposes only and should not be considered medical advice. Please consult a qualified healthcare professional for personalized guidance and treatment.